Linscomb & Williams, Inc. Viatris Inc Transaction History

Linscomb & Williams, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$12.09 - $14.68 $162,840 - $197,724	-13,469 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$13.25 - $15.13 $25,254 - $28,837	-1,906 Reduced 12.4%	13,469 $182,000
Q2 2021 Aug 10, 2021	SELL	$12.97 - $16.15 $35,019 - $43,604	-2,700 Reduced 14.94%	15,375 $220,000
Q1 2021 May 12, 2021	SELL	$13.59 - $18.54 $37,250 - $50,818	-2,741 Reduced 13.17%	18,075 $253,000
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $297,668 - $390,091	20,816 New	20,816 $390,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

Stay updated on Linscomb & Williams, Inc. with notifications on news.